Study

Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia. – Cost Effective Supplements

Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/2521069


Conclusion of this study

Subjects were 34 MID patients and 39 PDD patients who met entrance criteria for the study. A repeated measures ANOVA showed significant improvement in both patients with MID and patients with PDD for word fluency. The total score on the Relatives' Assessment of Global Symptomatology-Elderly showed significant improvement for patients with PDD. The average score on the Instrumental Activities of Daily Living Scale, however, showed a significant decline for patients with PDD.


Supplements analyzed in this study

Oxiracetam

Health conditions analyzed in this study

Mild Cognitive Impairment


Slightly Positive
Oxiracetam


Functions related to this study

Mental health


Slightly Positive
Oxiracetam


Body systems related to this study


Nervous System
Scroll to top